Pharma Equity Group A/S (CPH:PEG)

Pharma Equity Group Balance Sheet

Financials in millions DKK. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	4.23	4.23	2.83
Cash & Short-Term Investments	4.23	4.23	2.83
Cash Growth	0.07%	49.50%	-
Other Receivables	2.29	4.58	2.66
Receivables	60.29	62.58	2.66
Inventory	0.7	0.41	1.59
Prepaid Expenses	0.12	0.01	-
Other Current Assets	0	-	-
Total Current Assets	65.34	67.23	7.07
Property, Plant & Equipment	0.27	0.51	0.58
Other Intangible Assets	-	-	13.86
Other Long-Term Assets	-	-0	-
Total Assets	65.61	67.74	21.52
Accounts Payable	4.09	10.2	1.61
Accrued Expenses	0.98	1.14	0.06
Short-Term Debt	2.71	21.93	-
Current Portion of Leases	0.23	0.22	0.29
Other Current Liabilities	0.62	0.85	0.36
Total Current Liabilities	8.63	34.33	2.31
Long-Term Debt	8.1	7.84	-
Long-Term Leases	-	0.23	0.3
Total Liabilities	16.73	42.4	2.61
Common Stock	122.76	1,023	0.83
Comprehensive Income & Other	-73.88	-997.63	18.08
Shareholders' Equity	48.88	25.33	18.91
Total Liabilities & Equity	65.61	67.74	21.52
Total Debt	11.05	30.22	0.58
Net Cash (Debt)	-6.81	-25.99	2.25
Net Cash Per Share	-0.01	-0.02	0.00
Filing Date Shares Outstanding	1,228	1,023	953.97
Total Common Shares Outstanding	1,228	1,023	953.97
Working Capital	56.7	32.9	4.76
Book Value Per Share	0.04	0.02	0.02
Tangible Book Value	48.88	25.33	5.05
Tangible Book Value Per Share	0.04	0.02	0.01
Machinery	0.09	0.09	0.02

Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.